GlassScriptPhysician profile
Brandy F Franklin
NPI 1568400307
$6,527.64
in general payments reported to CMS, 2019-2025
31 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,493 · 2022: $1,211 · 2023: $1,364 · 2024: $1,208 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,823.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,735.33 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $752.16 | 2022-2025 | |
| Abbvie INC. | $698.93 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $477.40 | 2021-2025 | Spravato |
| Dexcom, INC. | $376.34 | 2022-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $223.37 | 2021-2025 | Trelegy Ellipta |
| Abbott Laboratories | $158.27 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $128.66 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $125.91 | 2021-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.48 | 2025 | Xifaxan |
| Amgen INC. | $82.99 | 2021-2025 | Repatha |
| Xeris Pharmaceuticals, INC. | $63.84 | 2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $62.65 | 2023-2024 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $56.94 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.42 | 2021-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $41.63 | 2025 | Gemtesa |
| Exact Sciences Corporation | $41.50 | 2025 | The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $40.23 | 2021 | |
| Biosense Webster, INC. | $40.18 | 2024 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.98 | 2023-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $36.29 | 2021-2022 | |
| Nevro Corp. | $36.11 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.00 | 2023 | |
| Edwards Lifesciences Corporation | $23.30 | 2024 | |
| Si-Bone, INC. | $22.28 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.99 | 2022 | |
| Corcept Therapeutics | $15.05 | 2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $14.72 | 2025 | Rexulti |
| Radius Health, INC. | $14.61 | 2023 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $14.61 | 2025 | Breztri |
| Agepha Pharma Fz LLC | $13.47 | 2025 | Lodoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.